Action Point Financial Planning’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Action Point Financial Planning's CYTK Position: Q3 2026 in Review
Action Point Financial Planning sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 32 shares — an estimated $2.56K sold.
Action Point Financial Planning first reported a position in CYTK in Q2 2026 and held it in 1 quarter. The position peaked at $2.56K in Q2 2026. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Action Point Financial Planning reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 32 Cytokinetics shares in Q3 2026, an estimated $2.56K.
- Action Point Financial Planning first reported a position in Cytokinetics in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's Cytokinetics position peaked at $2.56K in Q2 2026.
- 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.